PolyPid
PolyPid is a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing, and commercializing novel, locally administered therapies to improve surgical outcomes. Their proprietary PLEX platform enables localized, controlled, and prolonged drug release solutions, aiming to enhance patient outcomes in conditions such as infection, pain, inflammation, and cancer.
Industries
Nr. of Employees
medium (51-250)
Products
Local extended‑release doxycycline implant for surgical sites
An implantable matrix formulated to deliver doxycycline locally at surgical sites over approximately four weeks to reduce the risk of surgical site infections while limiting systemic exposure.
Antibiotic‑eluting β‑TCP granules for bone infection applications
Granular β‑tricalcium phosphate material formulated to elute antibiotics locally for treatment or prevention of bone‑related infections.
Local extended‑release doxycycline implant for surgical sites
An implantable matrix formulated to deliver doxycycline locally at surgical sites over approximately four weeks to reduce the risk of surgical site infections while limiting systemic exposure.
Antibiotic‑eluting β‑TCP granules for bone infection applications
Granular β‑tricalcium phosphate material formulated to elute antibiotics locally for treatment or prevention of bone‑related infections.
Services
Licensing of local sustained‑release delivery platform
Licensing or partnership arrangements to enable use of a localized sustained‑release drug delivery system by third parties for optimized local therapeutic delivery.
On‑site GMP manufacturing and process validation
Manufacturing services including GMP production and manufacturing process validation for platform-enabled products and clinical/commercial supply.
Licensing of local sustained‑release delivery platform
Licensing or partnership arrangements to enable use of a localized sustained‑release drug delivery system by third parties for optimized local therapeutic delivery.
On‑site GMP manufacturing and process validation
Manufacturing services including GMP production and manufacturing process validation for platform-enabled products and clinical/commercial supply.
Expertise Areas
- Localized drug delivery
- Sustained‑release formulation development
- Surgical therapeutics (surgical site infection prevention)
- Clinical trial management for surgical indications
Key Technologies
- Polymer‑lipid layered encapsulation matrices
- Controlled‑release drug reservoirs
- Antibiotic‑eluting beta‑tricalcium phosphate granules
- Local implantable extended‑release systems